Stock-Based Compensation - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 24, 2023 |
Sep. 25, 2022 |
Sep. 24, 2023 |
Sep. 25, 2022 |
|
| Stock-based compensation | $ 1,000 | $ 900 | $ 2,962 | $ 2,885 |
| Share-based Payment Arrangement, Option | ||||
| Award vesting period | 5 years | |||
| Maximum term | 10 years | |||
| Stock options outstanding (in shares) | 1,819 | 1,819 | ||
| Weighted average remaining contractual term | 1 year | |||
| Restricted Stock Units (RSUs) | ||||
| Unrecognized stock-based compensation expense related to non-vested restricted stock units | $ 9,100 | $ 9,100 | ||
| 2020 Plan | ||||
| Common stock reserved and available for issuance (in shares) | 743,117 | 743,117 | ||
| 2023 ESPP | ||||
| Common stock reserved and available for issuance (in shares) | 500,000 | 500,000 | ||
| Minimum | Restricted Stock Units (RSUs) | ||||
| Award vesting period | 4 years | |||
| Maximum | Restricted Stock Units (RSUs) | ||||
| Award vesting period | 5 years | |||
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|